Long-term outcomes of venous thrombosis in children

Current Opinion in Hematology

Volumn 12, Issue 5, 2005, Pages 370-376

  Goldenberg, Neil A ^a,b  

^a CHILDREN S HOSPITAL   (United States)

^b Mountain States Regional Hemophilia and Thrombosis Center   (United States)

Author keywords

Outcome; Post thrombotic syndrome; Recurrence; Thrombosis; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 8; D DIMER; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; REVIPARIN;

ANTICOAGULANT THERAPY; BLEEDING; BLOOD VESSEL OCCLUSION; CENTRAL VENOUS CATHETER; COHORT ANALYSIS; EPISTAXIS; FIBRINOLYTIC THERAPY; HUMAN; KIDNEY VEIN THROMBOSIS; LIMB; MORTALITY; OCCLUSIVE CEREBROVASCULAR DISEASE; PEDIATRICS; PORTAL VEIN THROMBOSIS; POSTTHROMBOSIS SYNDROME; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; TREATMENT OUTCOME; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

CATHETERIZATION, CENTRAL VENOUS; CHILD; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL THROMBOSIS; PORTAL VEIN; RENAL VEINS; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 24644494232     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moh.0000160754.55131.14     Document Type: Review

References (27)

1. Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: a report from the Canadian childhood thrombophilia registry. Pediatr Res 2000; 47:763-766.
2. van Ommen CH, Heijboer H, Büller HR, et al. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr 2001; 139:676-681.
3. Stein PD, Kayali F, Olson RE. Incidence of venous thromboembolism in infants and children: data from the National Hospital Discharge Survey. J Pediatr 2004; 145:563-565. This important analysis provided very recent data on the incidence of VTE in children and within specific pediatric age groups.
4. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and International Registry. Pediatrics 1995; 96:939-943.
5. Nowak-Göttl U, von Kries R, Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child 1997; 76:F163-F167.
6. Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med 2004; 351:1081-1088. This study evaluated the relevance to pediatric thrombosis of recently defined predictors of recurrent VTE in adults. Elevated factor VIII and D-dimer levels, whether at thrombus diagnosis or following 3-6 months standard anticoagulation therapy, were shown to be quite specific for poor outcomes of thrombosis in children, as reflected by persistent thrombosis, recurrent thromboembolism, or the development of the post-thrombotic syndrome.
7. Nowak-Göttl U, Junker R, Kruez W, et al. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood 2001; 97:858-862.
8. Nohe N, Flemmer A, Rümler R, et al. The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases. Eur J Pediatr 1999; 158:8134-5139.
9. Massicotte P, Julian JA, Gent M. An open-label randomized controlled trial of low molecular weight heparin compared to heparin and Coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial. Thromb Res 2003; 109:85-92.
10. van Ommen CH, Heijboer H, van den Dool EJ, et al. Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome. J Thromb Haemost 2003; 1:2516-2522.
11. Ören H, Devecioglu Ö, Ertem M, et al. Analysis of pediatric thrombotic patients in Turkey. Pediatr Hematol Oncol 2004; 21:573-583.
12. Revel-Vilk S, Sharathkumar A, Massicotte P, et al. Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound. J Thromb Haemost 2004; 2: 42-46. This large study evaluated the rate of persistent thrombosis three months following acute thrombotic events in children, and determined factors independently associated with lack of thrombus resolution.
13. Michaels LA, Gurian M, Hegyi T, et al. Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant. Pediatrics 2004; 114:703-707. This is one of the few cohort studies, albeit relatively small, to systematically evaluate the safety, efficacy, and outcomes of LMWH therapy for thrombosis in premature infants.
14. Manco-Johnson MJ, Knapp-Clevenger R, Miller BI, et al. Post-thrombotic syndrome (PTS) in children: validation of a new pediatric outcome instrument and results in a comprehensive cohort of children with extremity deep vein thrombosis (DVT). [Abstract] Blood 2003; 102:553a.
15. Goldenberg NA, Manco-Johnson MJ. Venous thrombosis in children [reply]. N Engl J Med 2004; 351:2451-2452.
16. Masicotte MP, Dix D, Monagle P, et al. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Peds 1998; 133:770-776.
17. Journeycake JM, Quinn CT, Miller KL, et al. Catheter-related deep venous thrombosis in children with hemophilia. Blood 2001; 98:1727-1731.
18. Mocan H, Beattie TJ, Murphy AV. Renal venous thrombosis in infancy: long-term follow-up. Pediatr Nephrol 1991; 5:45-49.
19. Nuss R, Hays T, Manco-Johnson M. Efficacy and safety of heparin anticoagulation for neonatal renal vein thrombosis. Am J Hematol Oncol 1994; 16: 127-131.
20. Keidan I, Lotan D, Gazit G, et al. Early neonatal renal venous thrombosis: long-term outcome. Acta Pediatr 1994; 83:1225-1227.
21. Kuhle S, Massicotte P, Chan A, et al. A case series of 72 neonates with renal vein thrombosis: data from the 1-800-NO-CLOTS Registry. Thromb Haemost 2004; 92:929-933.
22. Kosch A, Küwertz-Broking E, Heller C, et al. Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up. Blood 2004; 104:1356-1360. This is an interesting report of important long-term outcomes, including hypertension and recurrent VTE, from a large cohort study of children with RVT who underwent standardized clinical and radiologic follow-up.
23. deVeber G, Andrew M, Adams C, et al. Cerebral sinovenous thrombosis in children. N Engl J Med 2001; 345:417-423.
24. deVeber GA, MacGregor D, Curtis R, et al. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J Child Neurol 2000; 15:316-324.
25. Kenet G, Waldman D, Lubetsky A, et al. Paediatric cerebral sinus vein thrombosis. Thromb Haemost 2004; 92:713-718. This large study is among the few, since the prior work of deVeber and colleagues, to define the risk of recurrent VTE and to thoroughly evaluate neurologic outcomes following CSVT in children.
26. De Schryver ELLM, Blom I, Braun KPJ, et al. Long-term prognosis of cerebral venous sinus thrombosis in childhood. Dev Med Child Neurol 2004; 46: 514-519.
27. Gürakan F, Eren M, Koçak N, et al. Extrahepatic portal vein thrombosis in children: etiology and long-term follow-up. J Clin Gastroenterol 2004; 38:368-372.